Inhaled drug delivery: a randomized study in intubated patients with healthy lungs
Jonathan Dugernier(Cliniques Universitaires Saint-Luc), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Michel Hesse(Cliniques Universitaires Saint-Luc), Grégory Reychler(Cliniques Universitaires Saint-Luc), Stéphan Ehrmann(Inserm), Déborah Le Pennec(Université de Tours), Pierre Goffette(Ludovit Stur Institute of Linguistics of the Slovak Academy of Sciences), Christian Raftopoulos(Ludovit Stur Institute of Linguistics of the Slovak Academy of Sciences), Virginie Depoortere(Cliniques Universitaires Saint-Luc), Laurine Allimonnier(Université de Tours), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Guillaume Maerckx(Cliniques Universitaires Saint-Luc), Diego Castanares‐Zapatero(Cliniques Universitaires Saint-Luc), Jean-Bernard Michotte(HES-SO University of Applied Sciences and Arts Western Switzerland), François Jamar(Cliniques Universitaires Saint-Luc), Marie-Agnès Docquier(Cliniques Universitaires Saint-Luc), Laurent Vecellio(Université de Tours)
Cited by 13
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890